Now I have rich content from two OB textbooks. Let me compile a thorough, well-organized answer.
Postpartum Hemorrhage (PPH) in Obstetrics
Definition
- Primary (early) PPH: Blood loss >500 mL after vaginal delivery, or >1000 mL after cesarean delivery, within 24 hours of delivery
- Secondary (late) PPH: Abnormal bleeding occurring 24 hours to 6 weeks after delivery
- Clinically, any bleeding causing signs/symptoms of hemodynamic instability - or that would cause instability if untreated - qualifies as PPH, regardless of measured volume
Causes - The "4 Ts"
| Cause | Examples | Frequency |
|---|
| Tone (atony) | Failed uterine contraction | ~70-80% |
| Trauma | Cervical/vaginal/uterine lacerations, uterine rupture, uterine inversion | |
| Tissue | Retained placenta/membranes, placenta accreta | |
| Thrombin | DIC, hereditary coagulopathy, pre-eclampsia | |
Late PPH causes: Subinvolution of the placental site, retained placental fragments, infection, hereditary coagulopathy.
Risk Factors
For uterine atony:
- Uterine overdistension (polyhydramnios, multiple gestation, macrosomia)
- High parity
- Prolonged or rapid labor
- Oxytocin use
- Intraamniotic infection (chorioamnionitis)
- Uterine-relaxing agents (magnesium, tocolytics)
For cesarean delivery hemorrhage:
- Preeclampsia
- Active labor disorders
- Obesity
- General anesthesia
- Prior PPH history
Initial Assessment & Stabilization
- Monitor vital signs frequently
- Establish two large-bore IV lines
- Start IV crystalloid (lactated Ringer's)
- Prepare for blood transfusion (type and crossmatch)
- Supplemental oxygen
- Labs: CBC with platelets, fibrinogen, fibrin split products, PT, PTT
- Real-time ultrasound - identify retained placenta or blood clots
Management by Cause
1. Uterine Atony (most common)
Step 1 - Uterotonic agents (first-line):
| Drug | Dose/Route | Notes |
|---|
| Oxytocin | 20-30 units in 1000 mL IV at ≤100 mU/min | No IV bolus (causes hypotension). Risk of water intoxication with large volumes. |
| Methylergonovine / Ergonovine | 0.2 mg IM q2-4h | Contraindicated in hypertension (causes vasoconstriction). Never IV (risk of severe HTN, CNS vasospasm, hemorrhage). |
| Carboprost (15-methyl PGF2α / Hemabate) | 250 μg IM q15-90 min; max 8 doses | Caution in asthma and cardiovascular disease. Monitor O₂ saturation. |
| Misoprostol | 800-1000 μg rectally or transvaginally | Used when conventional pharmacotherapy fails. |
Bimanual uterine compression is performed alongside uterotonics.
Step 2 - Tamponade (if uterotonics fail):
- Bakri balloon or large Foley catheter - especially for low placental implantation site bleeding
- Uterine packing with sterile gauze
Step 3 - Interventional radiology:
- Selective embolization of pelvic vessels (where facilities are available)
Step 4 - Surgery (laparotomy):
- Patient positioned in semilithotomy
- Goals: identify occult bleeding sources, ligation of uterine/hypogastric (internal iliac) arteries
- B-Lynch suture or other compression sutures
- Hysterectomy as last resort
Internal iliac (hypogastric) artery ligation: reduces pulse pressure in pelvic vessels. Collateral circulation is ample; subsequent pregnancies are possible after this procedure.
2. Lacerations (Trauma)
- Inspect cervix, vagina, and perineum with good lighting and assistance
- Repair any identified lacerations
- Firm fundus + ongoing bleeding = suspect occult laceration or retained placenta
3. Retained Placenta / Placenta Accreta (Tissue)
- Manual exploration of uterine cavity
- Curettage for suspected retained fragments
- Placenta accreta: high suspicion required if previous uterine surgery; may require hysterectomy
4. Uterine Inversion
- Uncommon but life-threatening; associated with fundal placentation
- Do not remove placenta before reinversion if using the Johnson technique (easier without placenta in place)
- Johnson technique: firm upward pressure on fundus through vagina to elevate uterus into abdomen; hold several minutes
- Tocolysis aids reinversion: magnesium sulfate, β-mimetics, nitroglycerin (to relax the cervical ring)
- Surgical options if Johnson fails: Huntington procedure (traction on round ligaments via laparotomy) or Haultain procedure (posterior longitudinal incision through inverted fundus)
5. Coagulopathy (Thrombin)
- Treat underlying cause (DIC, preeclampsia, HELLP)
- Blood product replacement: packed RBCs, FFP, platelets, cryoprecipitate
- Tranexamic acid (TXA) - antifibrinolytic, recommended early in hemorrhage
Active Management of Third Stage of Labor (AMTSL) - Prevention
- Early administration of oxytocin (10 units IM at delivery of anterior shoulder, or after delivery)
- Early cord clamping
- Controlled cord traction
AMTSL reduces PPH by approximately two-thirds compared to expectant management.
Monitoring in Severe PPH
In extensive PPH, central venous pressure (CVP) monitoring or Swan-Ganz catheter placement helps guide fluid resuscitation and avoids pulmonary edema.
Recent Evidence (2025)
A
2025 Cochrane network meta-analysis (PMID 40237648) found that
carbetocin and combination uterotonic regimens may be superior to oxytocin alone for preventing PPH. A separate
2025 Cochrane systematic review (PMID 39911088) addresses blood product transfusion strategies in PPH management.
Sources: Creasy & Resnik's Maternal-Fetal Medicine, 8e; Textbook of Family Medicine, 9e